[25] Cancer [edit] In response to a report of precancerous changes in the pancreases of rats and organ donors treated with the DPP-4 inhibitor sitagliptin, [26] [27] the US FDA and the European Medicines Agency each undertook independent reviews of all clinical and preclinical data related to the possible association of DPP-4 inhibitors with pancreatic cancer
KH: Investigation, Writing original draft, Writing review & editing, Formal analysis, Validation
Some early research points to benefits, but long-term effects are unclear
The Precision Peptide Genetic Test may help provide context about your predisposition in peptide signaling pathwaysvariants in GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313which can support a more informed conversation with your provider about medication choice and expected dosing needs
Clinical evidence shows increased hair density with extended anagen (growth) phase, shortened telogen (rest) phase, and reduced catagen (regression) duration
Su P, Li S, Chen S, Lipina TV, Wang M, Lai TK, et al
